Mammography Market | Contrive Datum Insights

The Global Mammography market size was valued at $2,246.1 million in 2022, and is projected to reach $4,718.5 million by 2030, growing at CAGR of 10.26%.
{{info}}

The global mammography market refers to the market for diagnostic imaging equipment used for breast cancer screening and diagnosis. Mammography is a type of medical imaging that uses low-dose X-rays to produce images of the breast tissue.

The market for mammography equipment and services has been growing steadily over the past decade, driven by factors such as increasing awareness about breast cancer and the importance of early detection, as well as technological advancements in mammography equipment. The increasing incidence of breast cancer, rising geriatric population, and growing demand for minimally invasive procedures are some of the key factors driving market growth.

The market is highly competitive, with several key players including Hologic, Inc., GE Healthcare, Siemens Healthineers, Fujifilm Holdings Corporation, and Koninklijke Philips N.V. These companies are focused on developing new and advanced mammography equipment and services to cater to the growing demand for breast cancer screening and diagnosis.

Market Dynamics

Driving Factors

The global mammography market is driven by several factors, including:

Technological advancements in mammography equipment: The development of advanced mammography equipment, such as digital mammography, tomosynthesis, and breast MRI, has improved the accuracy and efficiency of breast cancer screening and diagnosis. This has also contributed to the growth of the mammography market.

Rising geriatric population: The incidence of breast cancer is higher in women over the age of 50, and the growing geriatric population worldwide is driving the demand for mammography equipment and services.

Increasing demand for minimally invasive procedures: Mammography is a non-invasive and relatively painless procedure, which is preferred by many women over more invasive procedures for breast cancer screening and diagnosis. The increasing demand for minimally invasive procedures is driving the growth of the mammography market.

Restraining Factors

While there are several driving factors contributing to the growth of the global mammography market, there are also some restraining factors that could potentially hinder its growth. These include:

Alternative screening methods: While mammography is the most common screening method for breast cancer, there are alternative methods such as ultrasound and MRI that can also be used for screening and diagnosis. This may impact the demand for mammography equipment and services.

Lack of awareness and access in certain regions: Despite increasing awareness about breast cancer, there are still many regions of the world where access to mammography equipment and services is limited, particularly in low- and middle-income countries.

Regulatory challenges: Regulatory requirements and approval processes can be time-consuming and expensive, which can limit the development and availability of new mammography equipment and services.

Challenges

There are several challenges that the global mammography market faces, which could impact its growth and development. Some of these challenges include:

Regulatory challenges: Regulatory requirements and approval processes can be time-consuming and expensive, which can limit the development and availability of new mammography equipment and services. Companies must comply with strict regulations to ensure the safety and efficacy of their products, which can be a challenge.

Increasing competition: The mammography market is highly competitive, with several key players competing for market share. This can make it challenging for smaller companies to enter the market and compete with established players.

Opportunity Analysis

An opportunity analysis of the global mammography market indicates several areas of potential growth and development. These include:

Emerging markets: There is significant potential for growth in emerging markets, particularly in Asia and Africa, where access to mammography equipment and services is limited. Companies can expand their market reach by developing affordable and accessible mammography equipment and services tailored to the needs of these markets.

Artificial intelligence: The use of artificial intelligence (AI) in mammography is an emerging trend, with the potential to improve the accuracy and efficiency of breast cancer screening and diagnosis. Companies can develop new AI-based technologies and services to improve mammography performance and enable early detection of breast cancer.

Mobile mammography: There is potential for growth in mobile mammography services, which can provide screening services in underserved and remote communities. Companies can invest in the development of mobile mammography units and services that can reach patients who are unable to access screening services in traditional healthcare settings.

Segmentation Analysis

Product Outlook

Analog mammography technology uses traditional X-ray film to capture images of the breast. Analog mammography is still used in some settings, but it has largely been replaced by digital mammography.

Digital mammography technology uses digital detectors to capture images of the breast, which can be displayed on a computer screen. Digital mammography has several advantages over analog mammography, including improved image quality, lower radiation exposure, and the ability to manipulate and store images electronically.

Magnetic resonance imaging (MRI) technology uses a powerful magnetic field and radio waves to create detailed images of the breast. Breast MRI is often used for high-risk women or for diagnostic purposes when mammography and ultrasound are inconclusive.

Nuclear medicine imaging technology uses small amounts of radioactive material to create images of the breast. Nuclear medicine imaging is less commonly used than other imaging modalities in breast cancer diagnosis and is typically used for staging and monitoring the response to treatment.

End Use Outlook

Hospitals are the largest end-user of mammography equipment and services, as they provide a wide range of healthcare services including breast cancer screening and diagnosis. Diagnostic imaging centers specialize in providing imaging services, including mammography, to patients referred by healthcare providers.

Regional Analysis

In terms of regional analysis, North America is currently the largest market for mammography, owing to a well-established healthcare infrastructure, high awareness about breast cancer screening, and favorable reimbursement policies. The United States is the largest market in North America, with a significant portion of the population being covered by insurance policies that cover mammography screening.
{{info2}}

Europe is the second-largest market for mammography, driven by factors such as increasing government initiatives to promote breast cancer screening, a high prevalence of breast cancer, and technological advancements in mammography equipment. The United Kingdom, Germany, and France are the major markets in Europe.

The Asia-Pacific region is expected to witness the fastest growth in the mammography market over the next few years, owing to factors such as a large patient population, increasing awareness about breast cancer screening, and improving healthcare infrastructure. The major markets in the region include China, India, and Japan.

Scope Of Report:

The Global Mammography Market has been segmented into:

By Product

• Film Screen Systems
• Digital Systems
• Analog Systems
• 3D Systems

By Technology

• Breast Tomosynthesis
• CAD Mammography
• Digital Mammography

By End-use

• Hospitals
• Specialty Clinics
• Diagnosis Centers
• Others

By Region

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Nordic Countries
    • Denmark
    • Finland
    • Iceland
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Market Players 

The global mammography market is highly competitive and fragmented, with numerous players vying for market share. Some of the key companies in the market are:

• Hologic Inc.
• Analogic Corporation,
• Canon Medical Systems Corporation,
• Fujifilm Corporation
• Siemens Healthcare
• Toshiba Medical Systems
• GE Healthcare
• Metaltronica
• Koninklijke Philips NV
• PLANMED OY

Hologic is a leading player in the mammography market, offering a range of Mammography, including digital mammography, 3D mammography, and breast biopsy systems. The company's products are used in hospitals, imaging centers, and clinics around the world.

GE Healthcare is a global leader in medical imaging and healthcare IT, offering a range of Mammography, including digital mammography, 3D mammography, and breast biopsy systems. The company's products are used in hospitals, imaging centers, and clinics around the world.

Siemens Healthineers is a global provider of medical imaging equipment and healthcare IT solutions, offering a range of Mammography, including digital mammography, 3D mammography, and breast biopsy systems. The company's products are used in hospitals, imaging centers, and clinics around the world.

Fujifilm is a leading provider of diagnostic imaging and medical informatics solutions, offering a range of Mammography, including digital mammography and 3D Mammography. The company's products are used in hospitals, imaging centers, and clinics around the world.

Strategic Developments

In September 2021, Siemens Healthineers announced that it had completed the acquisition of Varian Medical Systems, a leading provider of radiation oncology solutions, for $16.4 billion. The acquisition is expected to strengthen Siemens' position in the oncology market and help the company expand its portfolio of cancer care solutions.

In July 2021, Hologic announced that it had completed the acquisition of Mobidiag, a company that develops molecular diagnostic tests for infectious diseases. The acquisition is expected to help Hologic expand its offerings in the infectious disease testing market.

In May 2021, Fujifilm announced that it had completed the acquisition of Hitachi's diagnostic imaging business for $1.6 billion. The acquisition is expected to help Fujifilm expand its portfolio of medical imaging solutions and strengthen its position in the global healthcare market.

In January 2021, Philips announced that it had acquired Capsule Technologies, a leading provider of medical device integration and data technologies for hospitals and healthcare organizations. The acquisition is expected to help Philips expand its portfolio of connected care solutions.

In September 2020, Hologic announced that it had entered into a definitive agreement to acquire Biotheranostics, a company that develops molecular diagnostic tests for cancer. The acquisition is expected to help Hologic expand its offerings in the breast cancer diagnostics market.